211 related articles for article (PubMed ID: 34383385)
1. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
3. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
4. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
5. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
[TBL] [Abstract][Full Text] [Related]
6. ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Comb Chem High Throughput Screen; 2023; 26(1):135-148. PubMed ID: 35388751
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
8. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
9. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
10. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z
Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
[TBL] [Abstract][Full Text] [Related]
13. The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.
Li J; Shi H; Yuan Z; Wu Z; Li H; Liu Y; Lu M; Lu M
BMC Cancer; 2022 Jan; 22(1):108. PubMed ID: 35078433
[TBL] [Abstract][Full Text] [Related]
14. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of the CDK2 functions in neuroblastoma.
Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z
Mol Med Rep; 2018 Mar; 17(3):3951-3959. PubMed ID: 29328425
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
[TBL] [Abstract][Full Text] [Related]
18. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of PSMD14 in head and neck squamous cell carcinoma.
Schnoell J; Scheiflinger A; Al-Gboore S; Kadletz-Wanke L; Kenner L; Heiduschka G; Jank BJ
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2483-2490. PubMed ID: 35750900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]